White Powder 5 Mg / Vial Tesamorelin Peptide 99% Purity

Basic Information
Place of Origin: China
Brand Name: Hongbaiyi
Certification: COA, HPLC MR
Model Number: HBY-Tesamorelin
Minimum Order Quantity: 5box
Price: US$ 90-100 / box
Packaging Details: 5mg/vial, 10vials/box
Delivery Time: 3-5 work days after your payment
Payment Terms: MoneyGram, Western Union, T/T
Supply Ability: 4000kg/Month
Detail Information
Peptide Name: Tesamorelin CAS No.: 218949-48-5
Molecular Formula: C221H366N72O67S Molecular Weight: 5136
Peptide Purity: >99% Appearance: White,powder
Synonyms: Hex-hGRF, ThGRF(1-44), TH-9507, (Hexenoyl Trans-3)-hGRF(1-44)-NH2
High Light:

5 Mg / Vial Tesamorelin Peptide


99% Purity Tesamorelin Peptide


5 Mg / Vial peptide tesamorelin

Product Description

99% Purity White Powder 5 Mg/Vial Tesamorelin Peptide For Sale

White Powder 5 Mg / Vial Tesamorelin Peptide 99% Purity 0

Basic Information Form of Tesamorelin Peptide For Sale



Tesamorelin Peptide For Sale

Cas No.








Shelf Life

2 years


White powder


Brief Introduction of Tesamorelin Peptide For Sale


Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.Tesamorelin / Egrifta is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy, which consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.


Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism. Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes production and possible fat loss.


Product Image of Tesamorelin Peptide For Sale


White Powder 5 Mg / Vial Tesamorelin Peptide 99% Purity 1


Researchs of Tesamorelin Peptide For Sale


As a GHRH analogue, tesamorelin has all of the same effects as GHRH and GHRH analogues like sermorelin, GRF (1-29), CJC-1295, etc. The addition of trans-3-hexanoic acid to tesamorelin makes it more stable in human plasma and thus increases its half-life. Despite this increase in half-life, tesamorelin, like CJC-1295, preserves the physiological action of GHRH and thus has fewer side effects than similar molecules that obliterate normal pulsatile growth hormone (GH) release.


Tesamorelin and Lypodystrophy


The primary use for tesamorelin is in the treatment of HIV-associated lipodystrophy, which arises both as a consequence of HIV infection and as a side effect of antiretroviral therapy. In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body. The physiologic mechanism responsible for this is not clearly understood, but it is thought that commonly used protease inhibitors play a large role in the pathogenesis of lipodystrophy.


Patients suffering from lipodystrophy initially had diet, exercise, and a handful of ineffective medications to rely on for treatment. If those did not work, surgery was a last-ditch, often ineffective, and frequently complicated solution. In 2010, however, the FDA approved tesamorelin specifically for the treatment of HIV-associated lipodystrophy. The drug has been found to reduce adiposity by nearly 20% in this population . Research suggests that tesamorelin is approximately 4 times more effective in reducing adiposity than all of the other available therapies combined .


Tesamorelin Investigated in Cardiac Disease


People with HIV are at increased risk of developing cardiovascular disease (CVD), in part due to abnormal fat deposition and in part due to the actions of antiretroviral drugs themselves. Prevention of CVD in HIV-positive individuals is considered to be the most important medical intervention for long-term well-being, after highly active antiretroviral therapy (HAART) of course. Until recently, statins have been the cornerstone of medical management in this population.


Research shows that tesamorelin, in addition to decreasing lipodystrophy, also reduces triglyceride levels, total cholesterol levels, and non-HDL-C levels in HIV-positive patients. A 15% reduction in visceral adipose tissue by tesamorelin correlates with a 50 mg decrease in trigylceride levels, .


It is worth noting that ectopic fat deposition, as seen in lipodystrophy, is associated with inflammation. Inflammation of any kind is a risk factor for CVD. Visceral adipose tissue, liver fat, and epicardial fat are all independently associated with increased risk of CVD. By reducing ectopic fat deposition, tesamorelin directly decreases inflammation and an individual’s risk for CVD.


Package and Shipping of Tesamorelin Peptide For Sale


Package: 2mg/vial, 10vials/box

Shipping: With 3-5 days after your payment

Muscle Growth Thymosin Beta 4 99% TB 500 5mg/vial CAS: 77591-33-4 2


FAQ of Tesamorelin Peptide For Sale


Q1: Do you Accept Sample Order?

A: Yes. The smallest order we accept is one box.


Q2: Do you accept VISA business credit card?

A: Yes. VISA business credit card is in our payment .


Q3: Is there any discount?
A: Yes, if you want to purchase larger quantity, we can offer better price for you.


Q4: How long does it take to me if I order?

A: About 3-5 days upon recepient of payment.


Q5: What kind of transportation do you have?

A: We have many ways of transportations, eg: Air, Sea, Special Lines,TNT, FEDEX, EMS, ect.

Contact Details

Phone Number : +8618192109180

WhatsApp : +8618192109180